104 related articles for article (PubMed ID: 6416344)
1. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
Clarke KA; Stirk G
Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
[TBL] [Abstract][Full Text] [Related]
2. Motoneurone excitability during antidromically evoked inhibition after administration of a thyrotrophin releasing hormone (TRH) analogue.
Clarke KA; Parker AJ; Stirk GC
Neuropeptides; 1984 Sep; 4(5):403-11. PubMed ID: 6436727
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of motoneurone excitability by combined administration of 5-HT agonist and TRH analogue.
Clarke KA; Parker AJ; Stirk GC
Neuropeptides; 1985 Jun; 6(3):269-82. PubMed ID: 3160967
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the motor behaviours produced by the intrathecal administration of thyrotrophin-releasing hormone and thyrotrophin-releasing hormone analogues in the conscious rat.
Johnson JV; Fone KC; Havler ME; Tulloch IF; Bennett GW; Marsden CA
Neuroscience; 1989; 29(2):463-70. PubMed ID: 2498761
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).
Guiloff RJ; Stålberg E; Eckland DJ; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1633-40. PubMed ID: 3125307
[TBL] [Abstract][Full Text] [Related]
6. Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.
Ballard TM; Hunter AJ; Bennett GW
Psychopharmacology (Berl); 1996 Oct; 127(3):265-75. PubMed ID: 8912405
[TBL] [Abstract][Full Text] [Related]
7. TRH analogue affects information transfer through the ventrobasal thalamus.
Clarke KA
Neuropeptides; 1986 Jan; 7(1):31-9. PubMed ID: 3081829
[TBL] [Abstract][Full Text] [Related]
8. The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
Eckland DJ; Modarres-Sadeghi H; Lightman SL; Guiloff RJ
J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):803-4. PubMed ID: 2123237
[No Abstract] [Full Text] [Related]
9. Effects of a thyrotropin releasing hormone analogue on locomotor and other motor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1985 Apr; 6(2):101-12. PubMed ID: 3923383
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone (TRH) acts centrally to stimulate gastric contractility in rats.
Garrick T; Buack S; Veiseh A; Tache Y
Life Sci; 1987 Feb; 40(7):649-57. PubMed ID: 3100898
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
McTigue DM; Rogers RC; Stephens RL
Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin releasing hormone (TRH) and a degradation stabilized analogue (RX77368) stimulate phosphoinositide turnover in cultured astrocytes in a regionally specific manner.
McDermott AM; Dickinson SL; Wilkin GP
Neurochem Int; 1992 Apr; 20(3):307-13. PubMed ID: 1338971
[TBL] [Abstract][Full Text] [Related]
13. Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease.
Guiloff RJ; Eckland DJ; Demaine C; Hoare RC; MacRae KD; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1359-70. PubMed ID: 3119776
[TBL] [Abstract][Full Text] [Related]
14. Behavioral profile of the TRH analogue RX77368 in developing rats.
Jackson HC
Peptides; 1990; 11(5):897-901. PubMed ID: 2126622
[TBL] [Abstract][Full Text] [Related]
15. The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.
Coupland NJ; Bailey JE; Glue P; Nutt DJ
Br J Clin Pharmacol; 1995 Sep; 40(3):223-9. PubMed ID: 8527283
[TBL] [Abstract][Full Text] [Related]
16. Further studies on the effects of a thyrotropin releasing hormone analogue on locomotor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1986; 8(2):99-109. PubMed ID: 3093913
[TBL] [Abstract][Full Text] [Related]
17. Development of a radioimmunoassay for RX77368 (pGlu-His-3,3-dimethyl proline amide)--a stable analogue of thyrotrophin releasing hormone (TRH).
Lynn AG; Bennett GW
J Pharm Biomed Anal; 1991; 9(1):9-18. PubMed ID: 1904280
[TBL] [Abstract][Full Text] [Related]
18. Large enhancement of excitatory postsynaptic potentials and currents by thyrotropin-releasing hormone (TRH) in frog spinal motoneurones.
Lacey G; Nistri A; Rhys-Maitland ER
Brain Res; 1989 May; 488(1-2):80-8. PubMed ID: 2500999
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
McDermott AM; Wilkin GP; Dickinson SL
Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
[TBL] [Abstract][Full Text] [Related]
20. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion.
Ao Y; Go VL; Toy N; Li T; Wang Y; Song MK; Reeve JR; Liu Y; Yang H
Endocrinology; 2006 Dec; 147(12):6004-10. PubMed ID: 16959836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
